Wall St subdued as rate cut bets intact after employment revision figures

Wall Street indexes remained largely subdued on Tuesday, with a significant downward revision of 911,000 jobs over the past year reinforcing expectations for a Federal Reserve interest rate cut, maintaining bets for a 25 basis point reduction. While the Dow edged up, buoyed by UnitedHealth's 6.7% gain, the S&P 500 and Nasdaq saw slight declines amid broader market caution. Geopolitical tensions lifted oil prices, and notable individual stock movements included Nebius soaring 43.6% on a Microsoft deal, while Albemarle plunged 11.3% on lithium supply news, as investors await upcoming inflation data.

Analysis

U.S. equity markets exhibited a cautious and divergent tone, trading near record highs while digesting significant macroeconomic and company-specific news. The primary macro driver is a substantial downward revision of U.S. payrolls, which showed 911,000 fewer jobs created through March than previously estimated, reinforcing market expectations for a near-term Federal Reserve interest rate cut. According to CME's FedWatch tool, a 25 basis point reduction is fully priced in, though the market remains sensitive to any deviation from this consensus. This cautious sentiment is reflected in the mixed index performance, with the Dow Jones Industrial Average gaining 0.09% largely due to a 6.7% surge in UnitedHealth (UNH), while the S&P 500 and Nasdaq Composite posted minor declines of 0.04% and 0.06% respectively. Market breadth was negative, with declining issues outnumbering advancers, and sector performance was fragmented with the energy sector rising 1.1% on higher oil prices while the housing index fell 3.1%. Stock-specific catalysts created significant volatility; the AI infrastructure theme propelled Nebius (NBIS) up 43.6% on a $17.4 billion deal with Microsoft, while lithium producer Albemarle (ALB) plunged 11.3% on easing supply concerns after a Chinese competitor announced a production restart. Investors are now focused on upcoming producer and consumer inflation data to gauge the Fed's next move.

Key Decisions for Investors

• Investors should closely monitor the upcoming PPI and CPI inflation reports, as any data suggesting persistent price pressures could challenge the market's dovish Fed expectations and introduce significant volatility.
• The stark performance gap between Nebius (+43.6%) and Albemarle (-11.3%) underscores the need for a targeted thematic approach; AI infrastructure remains a potent source of growth, while commodity-linked equities face high event risk from supply-side news.
• Given the mixed market breadth and reliance on a few key stocks like UnitedHealth to support indices, consider reviewing portfolio concentration and hedging against potential disappointment from the Fed or negative surprises in upcoming earnings like Oracle's, which will be a key tell for AI demand.
• The negative reaction in Fox and News Corp shares following the Murdoch succession agreement highlights the importance of monitoring corporate governance and control structure changes as potential catalysts for repricing.